| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V98158 | ABBV-383 | ABBV-383 (ABBV-383) is a BCMA×CD3 bispecific T-cell engager (BiTE) that inhibits B-cell maturation protein activity (BCMA) and activates the T-cell surface glycoprotein CD3 complex. | |
|
V128378 | AFM15 | AFM15 is a humanized monoclonal antibody inhibitor that targets CD3E. | |
|
V118341 | Alveltamig | Alveltamig (ZG006) is a trispecific anti-T cell adaptor protein (Tri-TE) that targets Delta-like ligand 3 (DLL3) and CD3. | |
|
V106419 | Amtabafusp alfa | Amtabafusp alfa is a humanized IgG1?λ1 antibody directed against CD3E/CD4. | |
|
V119952 | Anafiltamig | 3009026-69-8 | Anafilmig is a trivalent monoclonal antibody inhibitor that targets CD79B, CD3E, and MS4A1. |
|
V106373 | Anti-Rat TCR alpha/beta Antibody (R73) | Anti-rat TCR alpha/beta antibody (R73) is a mouse-derived IgG1, kappa antibody inhibitor directed against rat TCR alpha/beta. | |
|
V106385 | Avitotamig | Avitotamig is a [H-γ1 _ L-κ-scFv heavy-κ]-dimer bispecific antibody targeting CD3E/CD33. | |
|
V130072 | Besufetamig | 3037124-22-1 | Besufetamig is a bispecific antibody that targets programmed death receptor 1 (PD-1) and the CD3ε chain. |
|
V130645 | Brenetafusp | 2736407-54-6 | Brenetafusp is a TCR/anti-CD3 bispecific fusion protein composed of a TCR that targets the PRAME peptide and an anti-CD3 scFv effector domain. |
|
V130924 | Cabotamig | 2755301-09-6 | Cabotamig is a humanized bispecific T-cell binding antibody that targets CDH17/CD3. |
|
V131705 | Ciduvectamig | 2412587-62-1 | Ciduvectamig is a monoclonal antibody against CD3E/TMEFF2 human IgG4κ. |
|
V131830 | Cizutamig | 2919209-65-5 | Cizutamig is a bispecific T-cell connector that targets BCMA and CD3. |
|
V131902 | Clesitamig | 2930861-48-4 | Clesitamig is a trispecific T cell adaptor containing two CD3/CD137 bispecific Fab fragments and one DLL3 Fab fragment. |
|
V106412 | Ebribafusp alfa | Ebribafusp alfa is an IgG4κ chimeric antibody directed against CD3E. | |
|
V135021 | Eliroptamig | 3064817-30-4 | Eliroptamig is a multispecific antibody that targets albumin, folate receptor α (FOLR1), and differentiation cluster 3 (CD3). |
|
V119953 | Emaretamig | 3051701-97-1 | Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. |
|
V135308 | Etentamig | 2490552-52-6 | Etentamig is a BCMA × CD3 bispecific T cell connector (BiTE) that inhibits the activity of B cell maturation antigen (BCMA) and activates the T cell surface glycoprotein CD3 complex. |
|
V135311 | Etevritamab | 2329692-74-0 | Etevritamab is a bispecific T-cell connector that targets EGFRvIII and CD3. |
|
V135802 | Faziprumig | 3059485-32-1 | Faziprumig is a monoclonal antibody against CD19, CD3ε, and human serum albumin, with dissociation constants (Kd) of 0.0738 nM, 7.997 nM, and 0.6 nM, respectively. |
|
V136304 | Forimtamig | 2649379-96-2 | Forimtamig is a GPRC5D×CD3 T cell binding bispecific antibody. |